Invention Grant
US09265783B2 Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
有权
组合物，包括三菌纲和表皮生长因子受体抑制剂化合物或其盐及其使用方法
- Patent Title: Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
- Patent Title (中): 组合物，包括三菌纲和表皮生长因子受体抑制剂化合物或其盐及其使用方法
-
Application No.: US14092323Application Date: 2013-11-27
-
Publication No.: US09265783B2Publication Date: 2016-02-23
- Inventor: Jin Q. Cheng , Said M. Sebti
- Applicant: University of South Florida
- Applicant Address: US FL Tampa
- Assignee: University of South Florida
- Current Assignee: University of South Florida
- Current Assignee Address: US FL Tampa
- Agency: Fanelli Haag PLLC
- Main IPC: A61K31/70
- IPC: A61K31/70 ; A61K31/7052 ; A61K31/7064 ; A61K31/7076 ; A61K45/06
Abstract:
This application relates to combination therapies including triciribine compounds and epidermal growth factor receptor inhibitor compounds, particularly erlotinib-like compounds and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.
Public/Granted literature
Information query
